Our experiments showed that Taiwanese patients with stages III and IV mCRC had higher VEGF-B and -D levels in tumor tissues than those with stages I and II non-mCRC and that patients with high-grade levels of VEGF-B and -D had a shorter overall survival and a shorter disease-free survival compared with those with low-grade expression. Here, VEGFB is linked to neoplasm.